PURPOSE: To investigate rates of structural and functional change in a large clinical population of glaucoma and glaucoma suspect patients. DESIGN: Retrospective cohort. METHODS: Twenty-nine thousand five hundred forty-eight spectral-domain optical coherence tomography (OCT) and 19,812 standard automated perimetry (SAP) tests from 6138 eyes of 3669 patients with ≥6 months of follow-up, 2 good quality spectral-domain OCT peripapillary retinal nerve fiber layer scans, and 2 reliable SAP tests were included. Data were extracted from the Duke Glaucoma Registry, a large database of electronic health records of patients from the Duke Eye Center and satellite clinics. Rates of change for the 2 metrics were obtained using linear mixed models, categorized according to pre-established cutoffs, and analyzed according to the severity of the disease. RESULTS: Average rates of change were -0.73 ± 0.80 μm per year for global retinal nerve fiber layer thickness and -0.09 ± 0.36 dB per year for SAP mean deviation. More than one quarter (26.6%) of eyes were classified as having at least a moderate rate of change by spectral-domain OCT vs 9.1% by SAP (P < .001). In eyes with severe disease, 31.6% were classified as progressing at moderate or faster rates by SAP vs 26.5% by spectral-domain OCT (P = .055). Most eyes classified as fast by spectral-domain OCT were classified as slow by SAP and vice versa. CONCLUSION: Although most patients under routine care had slow rates of progression, a substantial proportion had rates that could potentially result in major losses if sustained over time. Both structural and functional tests should be used to monitor glaucoma, and spectral-domain OCT still has a relevant role in detecting fast progressors in advanced disease.
PURPOSE: To investigate rates of structural and functional change in a large clinical population of glaucoma and glaucoma suspect patients. DESIGN: Retrospective cohort. METHODS: Twenty-nine thousand five hundred forty-eight spectral-domain optical coherence tomography (OCT) and 19,812 standard automated perimetry (SAP) tests from 6138 eyes of 3669 patients with ≥6 months of follow-up, 2 good quality spectral-domain OCT peripapillary retinal nerve fiber layer scans, and 2 reliable SAP tests were included. Data were extracted from the Duke Glaucoma Registry, a large database of electronic health records of patients from the Duke Eye Center and satellite clinics. Rates of change for the 2 metrics were obtained using linear mixed models, categorized according to pre-established cutoffs, and analyzed according to the severity of the disease. RESULTS: Average rates of change were -0.73 ± 0.80 μm per year for global retinal nerve fiber layer thickness and -0.09 ± 0.36 dB per year for SAP mean deviation. More than one quarter (26.6%) of eyes were classified as having at least a moderate rate of change by spectral-domain OCT vs 9.1% by SAP (P < .001). In eyes with severe disease, 31.6% were classified as progressing at moderate or faster rates by SAP vs 26.5% by spectral-domain OCT (P = .055). Most eyes classified as fast by spectral-domain OCT were classified as slow by SAP and vice versa. CONCLUSION: Although most patients under routine care had slow rates of progression, a substantial proportion had rates that could potentially result in major losses if sustained over time. Both structural and functional tests should be used to monitor glaucoma, and spectral-domain OCT still has a relevant role in detecting fast progressors in advanced disease.
Authors: Alessandro A Jammal; Atalie C Thompson; Eduardo B Mariottoni; Tais Estrela; Leonardo S Shigueoka; Samuel I Berchuck; Felipe A Medeiros Journal: Ophthalmology Date: 2020-06-21 Impact factor: 12.079
Authors: Alessandro A Jammal; Samuel I Berchuck; Eduardo B Mariottoni; Angelo P Tanna; Vital P Costa; Felipe A Medeiros Journal: Ophthalmology Date: 2021-08-30 Impact factor: 12.079
Authors: Ryan Caezar C David; Sasan Moghimi; Eren Ekici; Jiun L Do; Huiyuan Hou; James A Proudfoot; Alireza Kamalipour; Takashi Nishida; Christopher A Girkin; Jeffrey M Liebmann; Robert N Weinreb Journal: Am J Ophthalmol Date: 2021-04-25 Impact factor: 5.488
Authors: Swarup S Swaminathan; Alessandro A Jammal; Samuel I Berchuck; Felipe A Medeiros Journal: Am J Ophthalmol Date: 2021-03-26 Impact factor: 5.488
Authors: Vahid Mohammadzadeh; Erica Su; Alessandro Rabiolo; Lynn Shi; Sepideh Heydar Zadeh; Simon K Law; Anne L Coleman; Joseph Caprioli; Robert E Weiss; Kouros Nouri-Mahdavi Journal: Am J Ophthalmol Date: 2021-12-21 Impact factor: 5.488
Authors: Vahid Mohammadzadeh; Erica Su; Sepideh Heydar Zadeh; Simon K Law; Anne L Coleman; Joseph Caprioli; Robert E Weiss; Kouros Nouri-Mahdavi Journal: Transl Vis Sci Technol Date: 2021-04-01 Impact factor: 3.283
Authors: Swarup S Swaminathan; Samuel I Berchuck; Alessandro A Jammal; J Sunil Rao; Felipe A Medeiros Journal: Transl Vis Sci Technol Date: 2022-02-01 Impact factor: 3.283
Authors: Harsha L Rao; Srilakshmi Dasari; Narendra K Puttaiah; Zia S Pradhan; Sasan Moghimi; Kaweh Mansouri; Carroll A B Webers; Robert N Weinreb Journal: Am J Ophthalmol Date: 2021-07-25 Impact factor: 5.258
Authors: Alessandro A Jammal; Samuel I Berchuck; Atalie C Thompson; Vital P Costa; Felipe A Medeiros Journal: Invest Ophthalmol Vis Sci Date: 2020-11-02 Impact factor: 4.799